Science Explorer Back to mapMap
Discussion
Researcher · Meander Medisch Centrum · Netherlands

Josien C. Regelink

Josien C. Regelink publishes mostly in Hematology, Oncology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research and Chronic Lymphocytic Leukemia Research.

OpenAlex
World rank
#2,768,046
of 7,710,434 ranked researchers
Rank in Netherlands
#57,484
of 107,149
Works
28
Citations
836
Citations per work
29.9
h-index
9
i10-index 9Top 66% in Hematology
Josien C. Regelink

What does Josien C. Regelink research?

Josien C. Regelink's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 19 works · 66.3% of their workMedicine: 19 works · 66.3% of their workHematology: 8 works · 29.7% of their workOncology: 5 works · 18.9% of their workGenetics: 3 works · 9.5% of their workPathology and Forensic Medicine: 1 works · 4.1% of their workPhysiology: 1 works · 4.1% of their workEverything else: 7 works · 25.6% of their workLife Sciences: 2 works · 8.1% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 8.1% of their workMolecular Biology: 2 works · 8.1% of their workTHEIR WORKJosien C.Regelink28works
Life Sciences8%Health Sciences66%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1966.3%
  2. Everything else725.6%
    1. Biochemistry, Genetics and Molecular Biology28.1%
  1. 1Hematology30% of their works
  2. 2Oncology19% of their works
  3. 3Genetics10% of their works
  4. 4Molecular Biology8% of their works
  5. 5Pathology and Forensic Medicine4% of their works
  6. 6Physiology4% of their works

Research topics

Which keywords describe Josien C. Regelink's research?

The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Prognostic Factors, PET Imaging, Rituximab, Cancer Therapy, Acute Myeloid Leukemia and AML.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Diagnosis Criteria131 topic
  2. International Myeloma Working Group131 topic
  3. Prognostic Factors92 topics
  4. PET Imaging72 topics
  5. Rituximab72 topics
  6. Cancer Therapy62 topics
  7. AML51 topic
  8. Acute Myeloid Leukemia51 topic
  9. Chronic Lymphocytic Leukemia41 topic
  10. Fibroblast Activation Protein41 topic
  11. Genomic Aberrations41 topic
  12. Tumor Microenvironment41 topic
  13. Bisphosphonates31 topic
  14. Classification31 topic
  15. JAK2 Mutation31 topic
  16. Lymphoma31 topic
  17. Myelofibrosis31 topic
  18. Osteonecrosis of the Jaw31 topic
  19. HDAC Inhibitors21 topic
  20. Histone Deacetylases21 topic

Where does Josien C. Regelink work?

Josien C. Regelink's main affiliation in the publication record is Meander Medisch Centrum, Netherlands.

How many publications and citations does Josien C. Regelink have?

OpenAlex counts 28 works and 836 citations for Josien C. Regelink, an h-index of 9, ranking #2,768,046 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Josien C. Regelink. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.